Improving practice to eliminate high risk and prevent breast cancer
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) – a condition that significantly increases their risk of developing breast cancer – take advantage of available preventive therapies that can significantly reduce that risk.
In an effort to improve those rates, Abenaa Brewster, M.D., professor of Clinical Cancer Prevention, worked with colleagues...
Assets and obstacles in the fight to prevent HPV-related cancers
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...